Blood Coagulation & Fibrinolysis · 2009 · 14 citations · 36 references
MedicineHematologyImmunologyClinical BiochemistryHematology PhysiologyHemostasisPlatelet ActivationPlatelet AdhesionPlatelet AggregationPlatelet FunctionPlatelet PhysiologyThrombosisAdenosine Diphosphate-induced Platelet AggregationCd40l SignalingCold Storage RegimeP-selectin ExpressionPlatelet Activation AssaysPlatelet Responses To AgonistsPlatelet-leukocyte InteractionsWhole Blood Collection
To investigate platelet responsiveness during cold storage of whole blood, we examined platelet aggregation, expression of CD40 ligand (CD40L) on platelets, the plasma levels of soluble form of CD40L (sCD40L) as well as platelet-leukocyte aggregates. Flow cytometry analysis was performed to investigate platelet-leukocyte aggregate formation using antibodies against CD42b and CD45 and platelet activation using antibodies against P-selectin and PAC-1. Blood samples were collected from healthy volunteers, patients with cardiovascular diseases, or both. In the healthy volunteers' blood samples stored at 4 degrees C for 6 h, platelet aggregation in response to 1 micromol/l ADP was enhanced, and released levels of soluble form of P-selectin and thromboxane B2 in response to 1 micromol/l ADP markedly increased. In the samples stored at 4 degrees C for 6 h but not stimulated by any agonists, CD40L expression on the platelets was increased, and plasma levels of sCD40L were also elevated. Under the same condition, the increase in simultaneous expression of CD45 and CD42b was observed. In patients with cardiovascular diseases, the platelet aggregability, coexpression of P-selectin and PAC-1, expression of CD40L on platelets and both CD45-bound and CD42b-bound subsets were all comparable to those of healthy volunteers' samples stored at 4 degrees C for 6 h. Plasma levels of sCD40L in patients were higher than those in healthy volunteers' control. Taken together, storage of whole blood at 4 degrees C for 6 h caused platelet activation comparable to that of patients with cardiovascular diseases, and enhanced platelet activity in such patients may be involved in increased risk for thromboembolic events.
36
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Volker Henn, Joseph R. Slupsky, Michael Gräfe et al. · Nature · 1998 · 2.1K citations
Molecular and biological characterization of a murine ligand for CD40
Richard J. Armitage, William C. Fanslow, L Strockbine et al. · Nature · 1992 · 1K citations
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina
Pål Aukrust, Fredrik Müller, Thor Ueland et al. · Circulation · 1999 · 504 citations
Medicine, Cardiology, Immunology +17